D.C.’s LGBT AIDS programs get mixed reviews

Although the D.C. government is making good progress toward its ambitious goal of reducing the overall number of new HIV infections in the city by 50 percent in 2020, some of those at most risk for HIV/AIDS, especially LGBT people of color, “have been overlooked” in the city’s fight against AIDS, according to one of two independent reports released last week.

The report making the latter assertion, “Reclaiming The Right To Live: Reducing HIV/AIDS Disparities for LGB/Trans People of Color,” was prepared by student attorneys enrolled in Georgetown University Law Center’s Community Justice Project-Health Justice Alliance.

The report says the research on which its findings are based was conducted in partnership with Casa Ruby, the D.C. LGBT community services center that works closely with the transgender community. Its focus was on the city’s HIV/AIDS prevention efforts “as they relate to the LGB/Trans community and communities of color,” according to the report.

“Despite efforts to combat the epidemic in the District and general success with decreasing the number of cases in the last decade, these communities are disproportionately high risk for HIV,” the report says. “So while the District has had general success in fighting and preventing the spread of HIV, the most vulnerable and historically marginalized groups have been overlooked,” it says.

The report provides a number of recommendations for improving the city’s outreach to trans women and LGB people of color, including suggestions for improving the city’s data collection, which it says lumps transgender people together with gays, lesbians, and bisexuals.

It points out that a recent report by the D.C. Trans Coalition found that a staggering 20 percent of transgender people reported they were living with HIV, with 75 percent of them being people of color. The report also notes that D.C. data show that black men who have sex with men contracted HIV in 2016 at a rate of one in four compared to white men who have sex with men, who had an infection rate of one in eight.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below